Nef Inhibitors as Adjuvants Towards a Cure

Nef 抑制剂作为治疗的佐剂

• 批准号: 365645
• 负责人: Dikeakos Dimitrios J
• 金额: $ 18.05万
• 依托单位: University of Western Ontario
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-02-01 至 2018-08-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=365645&lang=en
• 关键词: Anti-Retrovirals; Hiv-1/Aids; Immune Evasion; Nef; Therapeutics; Viral Replication

Human Immunodeficiency Virus-1 (HIV-1) is the human virus responsible for Acquired Immune Deficiency Syndrome (AIDS). Specifically, the coordinated activity of multiple HIV-1 proteins results in infected patients progressing from the asymptomatic phase to

人类免疫缺陷病毒-1 (HIV-1) 是导致获得性免疫缺陷综合症 (AIDS) 的人类病毒。具体来说，多种 HIV-1 蛋白的协调活性导致感染患者从无症状阶段发展到感染阶段。